This study aimed to explore [1] the role of SMIT1 in DLBCL development, and [2] whether N6-Methyladenosine (m6A) modifications were responsible for high SMIT1 expression within DLBCL tissues. The gene discussed is SLC5A3; the disease is diffuse large B-cell lymphoma.